Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Execs Sign Three-Year Contract Extensions, Ensuring Management Continuity
LXRP CEO Chris Bunka and President John Docherty have agreed to new, three-year contracts The new contract agreements are designed to provide management security with continuity of key officers The company recently canceled 1,140,000 stock options after negotiations with optionees Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has successfully negotiated new three-year compensation contracts with key officers Chris Bunka, CEO, and John Docherty, president. The agreements offer LXRP and its shareholders the security of pursuing corporate growth within a seamless transition by providing management continuity. The renewal agreements are retroactive to January 1, 2019 (http://cnw.fm/q3UqT). The agreements offer both officers…